source
- Massachusetts biotech startups see funding gap widen as seed rounds shrink and Series A deals surgeA MassBio report shows that mature biotech firms in Massachusetts captured most of the venture capital in the first half of 2026, with nearly $3.5 billion invested, a 25% rise from the same period…
- Bristol Myers Squibb ends partnership with Cellares, prompting the cell therapy maker to restructureBristol Myers Squibb announced that it is terminating its collaboration with Cellares after completing a comprehensive evaluation of the partnership. The decision was driven by BMS’s assessment th…